Product Information
GNP DUAL ACTION PAIN 250-125 MG is a generic product labeled by AmerisourceBergen, priced at $0.1058 per EA under NDC 46122081861. Its NADAC has been published 48 times since Sep 24, 2025.
FDA first approved this application on Aug 1, 2023.
Strength
250; 125 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122081861
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216999FDA Approved
8/1/2023
On Market Since
5/15/2025
Pharmacological Classes
Price Statistics
The NADAC for GNP DUAL ACTION PAIN 250-125 MG has been published 48 times since Sep 24, 2025, and over the history we have for it it has risen 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1058 (Aug 19, 2026) |
| All-time low | $0.0839 (Apr 22, 2026) |
| 52-week high | $0.1058 |
| 52-week low | $0.0839 |
| Median price | $0.0900 |
| Average price | $0.0911 |
| Largest weekly change | +11.2% (Jul 22, 2026) |
| Weeks tracked | 48 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GNP DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for GNP DUAL ACTION PAIN 250-125 MG, manufactured by AmerisourceBergen, is $0.1058 per EA (NDC 46122081861), effective Aug 19, 2026.
How has the price of GNP DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has risen 18.6%. It has been tracked across 48 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for GNP DUAL ACTION PAIN 250-125 MG?
Since Sep 24, 2025, the NADAC for GNP DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.1058 (Aug 19, 2026), with a median of $0.0900 per EA.
Are there cheaper alternatives to GNP DUAL ACTION PAIN 250-125 MG?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 20% below GNP DUAL ACTION PAIN 250-125 MG.
Who manufactures GNP DUAL ACTION PAIN 250-125 MG?
GNP DUAL ACTION PAIN 250-125 MG (NDC 46122081861) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.